@Biotech2k1 Always appreciate your insights and approach!!
Do you have any opinions on CROs??
(Medpace $medp, iqvia $iqv, icon $iclr, PPD, Fortrea, etc)
Even J&J broke the streak after 2 yrs of day 1 adrenaline, yesterday’s silence was deafening.
The capital’s still here, just moving differently.
Why pay 50% premium for domestic M&A when you can license a derisked Shanghai asset on milestones?
Exclusive: Saks Global is preparing to file for bankruptcy in the coming weeks after missing an interest payment on the debt it took on to buy Neiman Marcus, people familiar with the matter said https://t.co/7B9zw5kOgR
On oncology trials, Ernest Hemingway once said "There are only three clinical outcomes worth measuring: ORR, PFS, and OS; all the rest are merely conference candy."
#Oncology